GT-300
- Generic Name
- GT-300
A Phase I Study of GT300 in Healthy Subjects
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Generian Pharmaceuticals, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT04963855
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath